drugset / Trial / NCT00031616

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

NCT00031616 ↗

Phase 1/2 Unknown NewBiotics
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of NB1011 in treating patients who have metastatic or recurrent colorectal cancer that has not responded to previous treatment.

Timeline

Start
2001-12
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject brivudine phosphoramidate Unknown — Intravenous

Indications